Direct and indirect approaches to identify drug modes of action
- 6 December 2017
- journal article
- review article
- Published by Wiley in IUBMB Life
- Vol. 70 (1) , 9-22
Abstract
Phenotypic assays are becoming increasingly more common among drug discovery practices, expanding drug target diversity as lead compounds identified through such screens are not limited to known targets. While increasing diversity is beneficial to the drug discovery process and the fight against disease, the unknown modes of action of new lead compounds can hamper drug discovery as, in most cases, the process of lead compound optimization is made difficult due to the unknown nature of the target; blindly changing substituents can prove fruitless due to the inexhaustible number of potential combinations, and it is therefore desirable to rapidly identify the targets of lead compounds developed through phenotypic screening. In addition, leads identified through target‐based screening often have off‐target effects that contribute towards drug toxicity, and by identifying those secondary targets, the drugs can be improved. However, the identification of a leads mode of action is far from trivial and now represents a major bottleneck in the drug discovery pipeline. This review looks at some of the recent developments in the identification of drug modes of action, focusing on phenotype‐based methods using metabolomics, proteomics, transcriptomics, and genomics to detect changes in phenotype in response to the presence of the drug, and affinity‐based methods using modified/unmodified drug as bait to capture and identify targets. © 2017 IUBMB Life, 70(1):9–22, 2018Keywords
This publication has 86 references indexed in Scilit:
- An accelerated workflow for untargeted metabolomics using the METLIN databaseNature Biotechnology, 2012
- Metabolomics: the apogee of the omics trilogyNature Reviews Molecular Cell Biology, 2012
- Using transcriptome sequencing to identify mechanisms of drug action and resistanceNature Chemical Biology, 2012
- High-throughput decoding of antitrypanosomal drug efficacy and resistanceNature, 2012
- Genome-wide RNAi screens in African trypanosomes identify the nifurtimox activator NTR and the eflornithine transporter AAT6Molecular and Biochemical Parasitology, 2011
- Identifying the proteins to which small-molecule probes and drugs bind in cellsProceedings of the National Academy of Sciences, 2009
- Analytical strategies for LC–MS-based targeted metabolomicsJournal of Chromatography B, 2008
- Mapping and quantifying mammalian transcriptomes by RNA-SeqNature Methods, 2008
- Metabolic networks in motion: 13C‐based flux analysisMolecular Systems Biology, 2006
- Chemical screening methods to identify ligands that promote protein stability, protein crystallization, and structure determinationProceedings of the National Academy of Sciences, 2006